Assay reveals potency of neutralising antibodies in COVID-19 patients
Researchers have shown that neutralising antibodies developed in COVID-19 patients were less potent if from those with severe or fatal disease.
List view / Grid view
Researchers have shown that neutralising antibodies developed in COVID-19 patients were less potent if from those with severe or fatal disease.
Using CRISPR-Cas9, scientists have developed a new method for generating mouse lines for vaccine research in just a few weeks.
A clinical study comparing liquid and tissue biopsies finds multiple resistance mechanisms in individual patients.
Harvard-led research boosts the yield of insulin-producing cells for diabetes therapy.
By surveying gene expression, researchers have created a reference atlas for understanding the biology of inflammatory bowel disease and food allergies, among other conditions...
Improved methods validate the use of blood samples for studying patients' cancer genomes
A new technique for modelling leukaemia may aid drug discovery...